GCG and Parkinson disease: Moreover, we previously found an effect of GLP-1 on neuroprotection via its reversal of age-induced neurodegeneration, such as that in Alzheimer's and Parkinson's diseases (51).We observed that GLP-1 not only inhibited mineralization but also reduced time-dependent calcification in AVICs from 7 to 21 days (Figure 4).